An Italian Multicenter Retrospective Observational Study to Assess Effectiveness and Safety of Siltuximab for Patients with Castleman's Disease Treated in Italy in a Real-life Context

NCT06720870 · clinicaltrials.gov ↗

RECRUITING

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Castleman Disease

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna